INMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Inmune Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.54−0.03 (-1.91%)
Close on Oct 19, 2026
- Market cap
- $41.15M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Inmune Bio's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 21, 2026 | Oct 21, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2026 | Sep 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2026 | Jul 31, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2026 | Jul 1, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2026 | Jun 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 16, 2026 | Jun 17, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2026 | Jun 2, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 29, 2026 | May 5, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 16, 2026 | Apr 23, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2026 | Feb 27, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 23, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 19, 2026 | Feb 19, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 10, 2026 | Feb 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 27, 2026 | Jan 27, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 22, 2025 | Dec 23, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2025 | Dec 19, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 5, 2025 | Dec 10, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 5, 2025 | Dec 8, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 1, 2025 | Dec 5, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 2, 2025 | Dec 3, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 26, 2025 | Nov 28, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 18, 2025 | Nov 18, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 30, 2025 | Oct 30, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Oct 30, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 23, 2025 | Oct 28, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Nov 18, 2025 | Oct 14, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 14, 2025 | Oct 14, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 29, 2025 | Sep 30, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2025 | Aug 7, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2025 | Jul 29, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 24, 2025 | Jul 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 27, 2025 | Jun 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jun 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2025 | Jun 26, 2025 | SEC EDGAR |